Navigating the Future of Oncology: Key Trends and Strategies
How 2,300 clinical trials and 700+ drugs in development will transform cancer care
Authored by Brad Aufderheide
Author
Brad Aufderheide
SVP, Oncology and Rare Disease Strategy
Brad leads oncology and rare disease strategy at Klick. With nearly 30 years in HCP and consumer healthcare marketing, he is a seasoned expert in leading over 30+ brand launches. His profound commitment to healthcare is evident in his work, which spans marketing strategy, lifecycle planning, market research, branding, and positioning. As a health educator, Brad incorporates adult learning, behavior-change theories, and health literacy in his approaches. He boasts over 15 years in oncology marketing, covering a wide array of types of cancer, and has a decade of experience in rare-disease marketing, supporting diverse brands across multiple conditions.
Related Content
Ready to Drive Life Sciences Forward?
Experience the transformative power of Klick Health, where deep industry expertise meets cutting-edge AI-driven wisdom.
As your trusted partners in life sciences commercialization, we combine a storied history in healthcare with the latest technologies to elevate every facet of your omnichannel strategy. From crafting engaging narratives to enabling data-driven decision-making, our integrated capabilities ensure you lead the way in transforming patient outcomes through digital health innovation.
Let’s create something transformative together.
